Is interruption of HIV therapy always harmful?
Open Access
- 1 February 2000
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 45 (2) , 137-138
- https://doi.org/10.1093/jac/45.2.137
Abstract
Human immunodeficiency virus (HIV) infection is associated with progressive immune damage leading to AIDS. Since the advent of combination antiretroviral chemotherapy clear morbidity and mortality benefits have been shown.1 Reversal of clinical disease and improvement in health status has resulted in a massive change in the epidemiology of HIV and AIDS2 and is seen as a remarkable therapeutic success story. However, these benefits have been accrued in spite of increasing evidence of long-term drug toxicity3 and with difficulty in compliance in taking this therapy.4Keywords
This publication has 10 references indexed in Scilit:
- Rapid decline in detectability of HIV-1 drug resistance mutations after stopping therapyAIDS, 1999
- The Dynamics of Human Cytomegalovirus Replication in VivoThe Journal of Experimental Medicine, 1999
- Dynamics of viral load rebound and immunological changes after stopping effective antiretroviral therapyAIDS, 1999
- Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: acohort studyThe Lancet, 1999
- HIV-1 rebound during interruption of highly active antiretroviral therapy has no deleterious effect on reinitiated treatmentAIDS, 1999
- In vivo HIV-1 replicative capacity in early and advanced infectionAIDS, 1999
- Emergence and takeover of YMDD motif mutant hepatitis B virus during long-term lamivudine therapy and re-takeover by wild type after cessation of therapyHepatology, 1998
- Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1998
- A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or LessNew England Journal of Medicine, 1997
- Decay characteristics of HIV-1-infected compartments during combination therapyNature, 1997